logo
Select company
Select metric
23.62%Cash to Assets Ratio
VS
Market
79
Sector
51
Industry
71
History
29
$ 7.79Close
$ 4.4 - $ 34 52-Week Range
Ticker Information

Ticker

BDSX

Company Name

BIODESIX INC

Sector

Healthcare

Industry

Diagnostics & Research

Exchange

NASDAQ

BIODESIX INC - Cash to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

BDSX - Cash to Assets Historical data
DateTotal AssetsCash and EquivalentsCash to Assets Ratio
6/30/2025$ 87.74M$ 20.73M23.62%
3/31/2025$ 86.24M$ 17.6M20.41%
12/31/2024$ 97.24M$ 26.25M26.99%
9/30/2024$ 102.74M$ 31.41M30.57%
6/30/2024$ 115.84M$ 42.22M36.45%
3/31/2024$ 87.2M$ 11.49M13.18%
12/31/2023$ 99.1M$ 26.28M26.52%
9/30/2023$ 86.79M$ 19.84M22.86%
6/30/2023$ 77.62M$ 17.41M22.43%
3/31/2023$ 80.79M$ 25.27M31.28%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • BIODESIX INC's latest trailing twelve months (TTM) Cash to Assets stands at 12.7%.
  • Over the past 5 years, BIODESIX INC's average Cash to Assets has been 31.16%.
  • The median Cash to Assets for BIODESIX INC during this period was 26.82%
  • BIODESIX INC reached its highest Cash to Assets over the past 5 years at 55.35%.
  • The lowest Cash to Assets recorded by BIODESIX INC in the same timeframe 12.7%

BIODESIX INC's Cash to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash to Assets Benchmarks
CompanyCash to Assets
TELA : TELA BIO INC 52.18%LUNG : PULMONX CORP 51.45%FONR : FONAR CORP 25.97%FBIO : FORTRESS BIOTECH INC 47.28%STRR1 : STAR EQUITY HOLDINGS INC 3.39%STRO : SUTRO BIOPHARMA INC 24.73%VNRX : VOLITIONRX LTD 25.92%MYO : MYOMO INC 37.79%IMDX : INSIGHT MOLECULAR DIAGNOSTICS INC 51.44%APYX : APYX MEDICAL CORP 50.36%

Definition of Cash to Assets Ratio

[Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for BIODESIX INC is calculated as follows: CashnEq [ $ 5.29M ] / Assets [ $ 41.63M ]
(=) Cash to Assets [ 12.7% ]

BDSX - Cash to Assets Ratio, Last 5 years

12.7%

Minimum

Dec 31, 2019

55.35%

Maximum

Jun 30, 2021

31.16%

Average

26.82%

Median

Cash to Assets Benchmark Analysis

The chart above depicts the distribution of Cash to Assets for companies in the Total Stock Market. The average Cash to Assets of the companies is 9.78% with a standard deviation of 9.53%.
The following table provides additional summary stats:
Cash to Assets in the Market:
filtered constituents3.94K
min0%
max40.76%
average9.78%
median6.42%
std9.53%